Dr. Lal Path Labs Ltd. (LALPATHLAB.NS)
Company Info
| ISIN | INE600L01024 |
|---|---|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Highlights
| Market Cap | ₹208.98B |
|---|---|
| EPS | ₹39.72 |
| PE Ratio | 63.23 |
| Revenue (TTM) | ₹21.72B |
| Gross Profit (TTM) | ₹11.68B |
| EBITDA (TTM) | ₹5.65B |
| Year Range | ₹1,897.01 - ₹2,753.60 |
| Target Price | ₹998.00 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: LALPATHLAB.NS vs. NFTY
Performance
Performance Chart
The chart shows the growth of an initial investment of ₹10,000 in Dr. Lal Path Labs Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Dr. Lal Path Labs Ltd. had a return of -0.62% year-to-date (YTD) and 30.30% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -0.62% | 11.18% |
| 1 month | 9.53% | 5.60% |
| 6 months | -5.08% | 17.48% |
| 1 year | 30.30% | 26.33% |
| 5 years (annualized) | 20.31% | 13.16% |
| 10 years (annualized) | N/A | 10.99% |
Monthly Returns
The table below presents the monthly returns of LALPATHLAB.NS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -2.34% | -6.12% | -3.78% | 4.84% | -0.62% | ||||||||
| 2023 | -7.04% | -5.33% | -8.11% | 6.91% | 4.01% | 11.14% | 2.96% | -5.99% | 16.01% | -4.17% | 11.52% | -4.45% | 14.62% |
| 2022 | -22.29% | -15.29% | 3.75% | -0.41% | -19.82% | 3.94% | 6.63% | 11.68% | -1.85% | 1.76% | -4.58% | -7.57% | -40.54% |
| 2021 | -2.51% | 2.62% | 17.66% | 8.34% | 0.80% | 10.70% | 8.93% | 14.10% | -9.25% | -4.57% | 8.00% | 0.87% | 66.87% |
| 2020 | 18.56% | -8.08% | -13.61% | 13.14% | -3.35% | 2.08% | 20.91% | -6.18% | 5.91% | 22.19% | 0.00% | 0.64% | 55.28% |
| 2019 | 18.49% | -6.24% | 6.21% | -2.77% | -0.64% | 3.09% | 1.69% | 14.76% | 11.93% | 10.39% | 2.35% | -4.72% | 65.26% |
| 2018 | 2.54% | 0.87% | -3.87% | -3.66% | 2.01% | 11.20% | -1.85% | 11.66% | -8.38% | -8.24% | -1.65% | 5.55% | 3.94% |
| 2017 | 4.20% | -12.64% | -0.63% | -0.79% | -5.81% | -13.52% | 6.87% | -2.79% | -1.63% | -3.12% | 15.37% | -0.96% | -17.30% |
| 2016 | -3.76% | 6.78% | 11.69% | 6.69% | -4.61% | -9.83% | 15.06% | 11.23% | -1.08% | 10.09% | -1.87% | -7.36% | 33.46% |
| 2015 | -2.49% | -2.49% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of LALPATHLAB.NS is 72, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
LALPATHLAB.NS (Dr. Lal Path Labs Ltd.)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Dr. Lal Path Labs Ltd. (LALPATHLAB.NS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Dr. Lal Path Labs Ltd. granted a 0.94% dividend yield in the last twelve months. The annual payout for that period amounted to ₹24.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₹24.00 | ₹12.00 | ₹12.00 | ₹20.00 | ₹12.00 | ₹9.50 | ₹5.50 | ₹4.50 | ₹2.45 |
Dividend yield | 0.94% | 0.47% | 0.53% | 0.52% | 0.52% | 0.64% | 0.60% | 0.51% | 0.23% |
Monthly Dividends
The table displays the monthly dividend distributions for Dr. Lal Path Labs Ltd.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | ₹0.00 | ₹12.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹12.00 | |||||||
| 2023 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹12.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹12.00 |
| 2022 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹6.00 | ₹0.00 | ₹6.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹12.00 |
| 2021 | ₹0.00 | ₹6.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹8.00 | ₹6.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹20.00 |
| 2020 | ₹0.00 | ₹0.00 | ₹6.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹6.00 | ₹0.00 | ₹12.00 |
| 2019 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹3.50 | ₹0.00 | ₹0.00 | ₹6.00 | ₹0.00 | ₹9.50 |
| 2018 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹3.00 | ₹0.00 | ₹0.00 | ₹2.50 | ₹0.00 | ₹5.50 |
| 2017 | ₹0.00 | ₹1.30 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹1.70 | ₹0.00 | ₹0.00 | ₹0.00 | ₹1.50 | ₹0.00 | ₹4.50 |
| 2016 | ₹2.45 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹2.45 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Dr. Lal Path Labs Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Dr. Lal Path Labs Ltd. was 57.48%, occurring on Mar 21, 2023. The portfolio has not yet recovered.
The current Dr. Lal Path Labs Ltd. drawdown is 38.48%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -57.48% | Sep 16, 2021 | 377 | Mar 21, 2023 | — | — | — |
| -40.72% | Sep 20, 2016 | 271 | Oct 24, 2017 | 456 | Aug 30, 2019 | 727 |
| -29.07% | Jan 30, 2020 | 36 | Mar 23, 2020 | 72 | Jul 9, 2020 | 108 |
| -19.79% | Apr 13, 2016 | 50 | Jun 24, 2016 | 46 | Aug 31, 2016 | 96 |
| -19.61% | Dec 28, 2015 | 18 | Jan 20, 2016 | 37 | Mar 15, 2016 | 55 |
Volatility
Volatility Chart
The current Dr. Lal Path Labs Ltd. volatility is 11.70%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |